【正文】
Disease Death Among NHANES I Epidemiologic FollowUp Study Participants According to Baseline BP Level and Category of Presumed Cardiovascular Risk Risk Group C Risk Group B Risk Group A 11 20 12 21 34 49 ≥160/ ≥100 18 31 27 44 273 394 140159/9099 21 37 36 60 486 701 130139/8589 Corrected* Uncorrected Corrected* Uncorrected Corrected* Uncorrected SBP/DBP, mmHg See test or Table 1 for deflnition of risk groups. *Corrected for regression dilution bias using a reliability coefficient or to correct for Imprecision in the measurement of SBP, 4. Estlmated Effect of a 12mmHg Reduction in SBP Over 10 years on the NumberNeededtoTreat to Prevent An AICause Death Among NHANES I Epidemiologic FollowUp Study Participants According to Baseline BP Level and Category of Presumed Cardiovascular Risk Risk Group C Risk Group B Risk Group A 9 16 9 17 23 37 ≥160/ ≥100 12 22 16 27 60 97 140159/9099 14 25 19 33 81 130 130139/8589 Corrected* Uncorrected Corrected* Uncorrected Corrected* Uncorrected SBP/DBP, mmHg See test or Table 1 for definition of risk groups. *Corrected for regression dilution bias using a reliability coefficient or to correct for Imprecision in the measurement of SBP 不同危險(xiǎn)程度高血壓患者的血壓水平(mmHg, x?s) 男 女 危險(xiǎn)度 SBP DBP SBP DBP 低危 () () () () 中危 () () () () 高危 () () () () 極高危 ()* () ()* () * P 心血管危險(xiǎn)度分層的重要性 (一) ? 高血壓常常伴隨其它危險(xiǎn)因素 ? 降壓治療的目的是減少心血管發(fā)病與死亡( CVD Risk) ,而不僅是降低血壓( RFs),所以對心血管危險(xiǎn)的估算是不可或缺的 ? 血壓升高是 CVD RR 的重要指標(biāo),故以往只看血壓水平?jīng)Q定治療策略。 177。 超聲心動圖: LVMI 男 ? 125,女 ? 110g/m2) ? 超聲證實(shí)動脈壁增厚 (頸動脈 IMT ? )或粥樣硬化斑塊 ? 血清肌酐輕微